Pyridoxamine Reverts Methylglyoxal-induced Impairment of Survival Pathways During Heart Ischemia

Methylglyoxal promotes oxidative stress and endothelial dysfunction

(2012) Cristina M. Sena et al.   PHARMACOLOGICAL RESEARCH

Methylglyoxal causes structural and functional alterations in adipose tissue independently of obesity

(2012) P. Matafome et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice

(2010) A. M. D. Watson et al.   DIABETOLOGIA

Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress

(2010) O. Brouwers et al.   DIABETOLOGIA

Methylglyoxal-modified collagen promotes myofibroblast differentiation

(2010) Amy Yuen et al.   MATRIX BIOLOGY

Cardiovascular Disease Risk Factors, Type 2 Diabetes Mellitus, and the Framingham Heart Study

(2010) Caroline S. Fox   TRENDS IN CARDIOVASCULAR MEDICINE

Hyperglycemia and Glycation in Diabetic Complications

(2009) Anne Negre-Salvayre et al.   ANTIOXIDANTS & REDOX SIGNALING

Prevention of arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenic glycation on aortic collagen

(2009) Kuo-Chu Chang et al.   BRITISH JOURNAL OF PHARMACOLOGY

The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues

(2009) H. Thangarajah et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Methylglyoxal mediates vascular inflammation via JNK and p38 in human endothelial cells

(2008) Hideyuki Yamawaki et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy

(2008) Heng Ma et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Blockade of the advanced glycation end products (AGEs) and their receptor (RAGE) system is a possible mechanism for sustained beneficial effects of multifactorial intervention on mortality in type 2 diabetes

(2008) S. Yamagishi et al.   MEDICAL HYPOTHESES

Therapeutic association of atorvastatin and insulin in cardiac ischemia: Study in a model of type 2 diabetes with hyperlipidemia

(2008) P MATAFOME et al.   PHARMACOLOGICAL RESEARCH